Recombinant IL5 (Mepolizumab Biosimilar) antibody

Catalog No. ABIN7597819

The Humanized Chimeric anti-IL5 (Mepolizumab Biosimilar) antibody has been validated for not_set. It is suitable to detect IL5 (Mepolizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL5 (Mepolizumab Biosimilar) antibody (ABIN7597819)

Target: IL5 (Mepolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IL5 (Mepolizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL5 (Mepolizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Mepolizumab Biosimilar Antibody

Specificity: IL5, B-cell differentiation factor I, IL-5, T-cell replacing factor, TRF, Eosinophil differentiation factor, Interleukin-5

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.44 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL5 (Mepolizumab Biosimilar)

Target: IL5 (Mepolizumab Biosimilar)

Alternative Name: Mepolizumab Biosimilar

Target Type: Biosimilar

Background: IL5, B-cell differentiation factor I, IL-5, T-cell replacing factor, TRF, Eosinophil differentiation factor, Interleukin-5

UniProt: P05113

CAS-No: 196078-29-2